Indena at DCAT Week 2026

Indena continues to advance its high-potency platform with ongoing investments in infrastructure and technology.
Our Settala site is fully equipped to manage HPAPI projects with Occupational Exposure Limits down to 1 ng/m³, supported by state-of-the-art high-containment production lines, new research laboratories, and integrated capabilities ranging from fermentation to complex chemical synthesis.

With over 35 years of experience in HPAPIs and a strong focus on oncology and ADC components, we provide flexible, end-to-end CDMO solutions — from early clinical development to commercial supply.

Meet our experts in New York to discover how our next-generation CDMO capabilities can support your most demanding projects.